To me the successful CureVac phase I trial for Rabies suggests that they do have a solution for the general targeting.
Given that Moderna is already doing their human trials this month and Biontic next month it seems they also have the problem of delievery to cells-in-general solved.
To me the successful CureVac phase I trial for Rabies suggests that they do have a solution for the general targeting.
Given that Moderna is already doing their human trials this month and Biontic next month it seems they also have the problem of delievery to cells-in-general solved.